Keywords: kissei/ciba/astra, agreement, kissei, pharmaceutical, ciba, japan, astra

Kissei/Ciba/Astra Agreement

Article | 20 February 1995

Print This

- Kissei Pharmaceutical, Ciba Japan and Astra Japan have entered into an agreement to market the calcium antagonist Splendil (felodipine) in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in